Freda M Miller

Title: Innovator Spotlight: Freda M. Miller – Pioneering Research in Neuroblastoma Treatment

Introduction: Freda M. Miller, based in Toronto, Canada, is a prominent inventor recognized for her groundbreaking contributions to the field of cancer research. With a focus on neuroblastoma, her work has paved the way for innovative approaches to identifying therapeutic agents and personalizing treatment for patients.

Latest Patents: Freda Miller holds a patent titled "Cancer stem cells and uses thereof." This patent discloses enriched preparations of neuroblastoma tumor initiating cells (NB TICs) that possess the ability to self-renew and initiate tumor growth. These NB TICs are notable for their chromosomal abnormalities and their capacity to generate secondary tumor spheres. The patent also outlines methods for preparing these enriched preparations from neuroblastoma tumor tissue and metastasized bone marrow. Furthermore, it describes screening methods for identifying candidate substances that can serve as therapeutic agents for neuroblastoma and provides tools for testing samples to ascertain neuroblastoma presence and its stage. A unique aspect of her research includes kits designed to create personalized medicinal profiles for patients based on their specific tumor initiating cells.

Career Highlights: Throughout her career, Freda has made significant strides in the medical community as a researcher at the Hospital for Sick Children. Her dedication to advancing cancer treatment has earned her recognition and respect among her peers.

Collaborations: Freda collaborates with a talented team of colleagues, including Loen M. Hansford and Kristen Michelle Smith, who contribute their expertise to enhance the impact of her research. Together, they work towards advancing therapeutic options for children affected by neuroblastoma.

Conclusion: Freda M. Miller exemplifies the spirit of innovation within the field of cancer research. Through her patent on cancer stem cells and their applications, she is not only contributing to the scientific community but also providing hope for families facing neuroblastoma. Her research demonstrates the power of collaboration and the importance of personalized medicine in the fight against cancer.